NHS National Generic Pharmaceuticals - Wave 16a
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-051c3a
Description
NHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 01/02/2027 to 31/01/2029 (24 months)
DNW: 01/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)
Notices
UK6: Contract award notice
- Notice identifier
- 2026/S 000-082784
- Published
- 1 September 2026, 3:46pm
UK4: Tender notice
- Notice identifier
- 2026/S 000-041573
- Published
- 6 May 2026, 3:34pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2026/S 000-037725
- Published
- 24 April 2026, 3:58pm
UK1: Pipeline notice
- Notice identifier
- 2025/S 000-024361
- Published
- 21 May 2025, 6:41pm